Find More Contacts for Santander
Protected Content
CIO, Project Manager
Executive Management
1 email found
View contacts for Santander to access new leads and connect with decision-makers.
View All Contacts

Details

Edit Details Section
  • Investor Type  Investment Bank
  • Investment Stage  Early Stage Venture, Private Equity, Seed
  • Number of Exits 
    15
  • Contact Email accionistas@santander.com
  • Phone Number +34 912 890 000
Santander is a financial services platform. They provide financial services. Their financial services platform provides services to individuals, SMEs, corporates, financial institutions, and governments. They operate commercial banking, wholesale banking, asset management, private banking, and retail banking subsidiaries.

Lists Featuring This Company

Edit Lists Featuring This Company Section
Financial Services Companies With More Than $100M in Revenue
5,530 Number of Organizations • $626.4B Total Funding Amount • 5,763 Number of Investors
Madrid Companies With More Than $1M in Revenue
7,560 Number of Organizations • $30.6B Total Funding Amount • 1,529 Number of Investors
Financial Services Public Companies With More Than $1B in Revenue
517 Number of Organizations • $292.7B Total Funding Amount • 554 Number of Investors
Europe Public Companies With More Than $100M in Revenue
1,710 Number of Organizations • $498.2B Total Funding Amount • 1,389 Number of Investors

Sub-Organizations

Edit Sub-Organizations Section
Number of Sub-Orgs 5
Which industries do these Sub-Organization operate in?

Frequently Asked Questions

Edit Frequently Asked Questions Section
Where is Santander's headquarters? Santander is located in Boadilla Del Monte, Madrid, Spain.Who invested in Santander? Santander has 2 investors including Warburg Pincus and General Atlantic.When was the last funding round for Santander? Santander closed its last funding round on May 30, 2013 from a Post-IPO Equity round.Who are Santander's competitors? Alternatives and possible competitors to Santander may include HSBC, UniCredit, and Sagicor.